Ionis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US4622221004

SecurityIONS / Ionis Pharmaceuticals, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership65,949 shares
Latest Disclosed Value $ 4,952,110
Walleye Capital LLC ownership in IONS / Ionis Pharmaceuticals, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 65,949 shares of Ionis Pharmaceuticals, Inc. (US:IONS) valued at $4,952,110 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 325 shares of Ionis Pharmaceuticals, Inc.. This represents a change in shares of 20,192.00% during the quarter. The current value of the position is $4,911,882 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (IONS) in the form of stock options. The firm currently holds call options representing 17,400 of underlying shares valued at $1,306,566 USD and put options representing 1,500 of underlying shares valued at $112,635 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IONS / Ionis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 IONIS PHARMACEUTICALS COM 462222100 65,949 65,624 20,192.00 4,952 19,708.00 0.0206
2026-05-08 2026-03-31 13F IONIS PHARMACEUTICALS COM 462222100 65,949 65,624 4,952 0.0206
2026-02-13 2025-12-31 13F IONIS PHARMACEUTICALS COM 462222100 325 325 26 0.0001
2025-11-14 2025-09-30 13F IONIS PHARMACEUTICALS COM 462222100 0 -66,482 -100.00 0 -100.00
2025-08-13 2025-06-30 13F IONIS PHARMACEUTICALS COM 462222100 66,482 -28,508 -30.01 2,627 -8.34 0.0102
2025-05-14 2025-03-31 13F IONIS PHARMACEUTICALS COM 462222100 94,990 78,735 484.37 2,866 404.40 0.0129
2025-02-13 2024-12-31 13F IONIS PHARMACEUTICALS COM 462222100 16,255 -107,861 -86.90 568 -88.58 0.0014
2024-11-14 2024-09-30 13F IONIS PHARMACEUTICALS COM 462222100 124,116 26,245 26.82 4,972 6.60 0.0103
2024-08-14 2024-06-30 13F IONIS PHARMACEUTICALS COM 462222100 97,871 8,741 9.81 4,665 20.74 0.0083
2024-05-15 2024-03-31 13F IONIS PHARMACEUTICALS COM 462222100 89,130 89,130 3,864 0.0069
2023-08-14 2023-06-30 13F IONIS PHARMACEUTICALS COM 462222100 0 -2,240 -100.00 0 -100.00
2023-05-15 2023-03-31 13F IONIS PHARMACEUTICALS COM 462222100 2,240 -23,814 -91.40 80 -91.87 0.0012
2023-02-14 2022-12-31 13F IONIS PHARMACEUTICALS COM 462222100 26,054 -59,909 -69.69 984 -74.12 0.0179
2022-11-14 2022-09-30 13F IONIS PHARMACEUTICALS COM 462222100 85,963 79,594 1,249.71 3,802 1,511.02 0.0726
2022-08-19 2022-06-30 13F/A-1 IONIS PHARMACEUTICALS COM 462222100 6,369 6,369 236 0.0065
2022-08-08 2022-06-30 13F IONIS PHARMACEUTICALS COM 462222100 6,369 6,369 236 0.0065
2022-05-27 2021-12-31 13F/A-01 IONIS PHARMACEUTICALS COM 462222100 0 -15,470 -100.00 0 -100.00
2022-03-03 2021-12-31 13F IONIS PHARMACEUTICALS COM 462222100 0 -15,470 0
2021-11-15 2021-09-30 13F IONIS PHARMACEUTICALS COM 462222100 15,470 15,470 519 0.0147
2019-11-14 2019-09-30 13F IONIS PHARMACEUTICALS COM 462222100 0 -170 -100.00 0 -100.00
2019-08-14 2019-06-30 13F IONIS PHARMACEUTICALS COM 462222100 170 -1,490 -89.76 11 -91.85 0.0012
2019-08-14 2019-03-31 13F/A-1 IONIS PHARMACEUTICALS COM 462222100 1,660 1,660 135 0.0222
2019-05-15 2019-03-31 13F IONIS PHARMACEUTICALS COM 462222100 1,660 135
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A IONIS PHARMACEUTICALS COM Call 17,400 75.76 1,307 66.79 n/a n/a n/a
2026-05-08 2026-03-31 13F IONIS PHARMACEUTICALS COM Call 17,400 1,307 n/a n/a n/a
2026-02-13 2025-12-31 13F IONIS PHARMACEUTICALS COM Call 9,900 98.00 783 139.45 n/a n/a n/a
2025-11-14 2025-09-30 13F IONIS PHARMACEUTICALS COM Call 5,000 -53.27 327 -22.51 n/a n/a n/a
2025-08-13 2025-06-30 13F IONIS PHARMACEUTICALS COM Call 10,700 -21.32 423 2.93 n/a n/a n/a
2025-05-14 2025-03-31 13F IONIS PHARMACEUTICALS COM Call 13,600 -8.72 410 -21.15 n/a n/a n/a
2025-02-13 2024-12-31 13F IONIS PHARMACEUTICALS COM Call 14,900 -26.60 521 -36.04 n/a n/a n/a
2024-11-14 2024-09-30 13F IONIS PHARMACEUTICALS COM Call 20,300 -26.45 813 -38.17 n/a n/a n/a
2024-08-14 2024-06-30 13F IONIS PHARMACEUTICALS COM Call 27,600 9,100.00 1,315 10,015.38 n/a n/a n/a
2024-05-15 2024-03-31 13F IONIS PHARMACEUTICALS COM Call 300 0.00 13 -13.33 n/a n/a n/a
2024-02-14 2023-12-31 13F IONIS PHARMACEUTICALS COM Call 300 -95.08 15 -94.57 n/a n/a n/a
2023-11-21 2023-09-30 13F/A IONIS PHARMACEUTICALS COM Call 6,100 1,425.00 277 1,625.00 n/a n/a n/a
2023-11-14 2023-09-30 13F IONIS PHARMACEUTICALS COM Call 6,100 277 n/a n/a n/a
2023-08-14 2023-06-30 13F IONIS PHARMACEUTICALS COM Call 400 -95.74 16 -95.22 n/a n/a n/a
2023-05-15 2023-03-31 13F IONIS PHARMACEUTICALS COM Call 9,400 168.57 336 153.79 n/a n/a n/a
2023-02-14 2022-12-31 13F IONIS PHARMACEUTICALS COM Call 3,500 132 n/a n/a n/a
2020-05-15 2020-03-31 13F IONIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F IONIS PHARMACEUTICALS COM Call 8,100 -43.75 489 -43.34 n/a n/a n/a
2019-11-14 2019-09-30 13F IONIS PHARMACEUTICALS COM Call 14,400 13.39 863 5.76 n/a n/a n/a
2019-08-14 2019-06-30 13F IONIS PHARMACEUTICALS COM Call 12,700 408.00 816 301.97 n/a n/a n/a
2019-08-14 2019-03-31 13F/A IONIS PHARMACEUTICALS COM Call 2,500 203 n/a n/a n/a
2019-05-15 2019-03-31 13F IONIS PHARMACEUTICALS COM Call 2,500 203 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A IONIS PHARMACEUTICALS COM Put 1,500 -86.24 113 -87.01 n/a n/a n/a
2026-05-08 2026-03-31 13F IONIS PHARMACEUTICALS COM Put 1,500 113 n/a n/a n/a
2026-02-13 2025-12-31 13F IONIS PHARMACEUTICALS COM Put 10,900 98.18 862 140.11 n/a n/a n/a
2025-11-14 2025-09-30 13F IONIS PHARMACEUTICALS COM Put 5,500 25.00 360 107.51 n/a n/a n/a
2025-08-13 2025-06-30 13F IONIS PHARMACEUTICALS COM Put 4,400 -71.61 174 -62.96 n/a n/a n/a
2025-05-14 2025-03-31 13F IONIS PHARMACEUTICALS COM Put 15,500 -45.61 468 -53.11 n/a n/a n/a
2025-02-13 2024-12-31 13F IONIS PHARMACEUTICALS COM Put 28,500 345.31 996 289.06 n/a n/a n/a
2024-11-14 2024-09-30 13F IONIS PHARMACEUTICALS COM Put 6,400 -82.98 256 -85.71 n/a n/a n/a
2024-08-14 2024-06-30 13F IONIS PHARMACEUTICALS COM Put 37,600 1,039.39 1,792 1,153.15 n/a n/a n/a
2024-05-15 2024-03-31 13F IONIS PHARMACEUTICALS COM Put 3,300 -61.63 143 -67.13 n/a n/a n/a
2024-02-14 2023-12-31 13F IONIS PHARMACEUTICALS COM Put 8,600 -60.19 435 -55.57 n/a n/a n/a
2023-11-21 2023-09-30 13F/A IONIS PHARMACEUTICALS COM Put 21,600 -27.27 980 -19.62 n/a n/a n/a
2023-11-14 2023-09-30 13F IONIS PHARMACEUTICALS COM Put 21,600 980 n/a n/a n/a
2023-08-14 2023-06-30 13F IONIS PHARMACEUTICALS COM Put 29,700 49.25 1,219 71.31 n/a n/a n/a
2023-05-15 2023-03-31 13F IONIS PHARMACEUTICALS COM Put 19,900 711 n/a n/a n/a
2020-05-15 2020-03-31 13F IONIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F IONIS PHARMACEUTICALS COM Put 100 -88.89 6 -88.89 n/a n/a n/a
2019-11-14 2019-09-30 13F IONIS PHARMACEUTICALS COM Put 900 -70.00 54 -72.02 n/a n/a n/a
2019-08-14 2019-06-30 13F IONIS PHARMACEUTICALS COM Put 3,000 400.00 193 293.88 n/a n/a n/a
2019-08-14 2019-03-31 13F/A IONIS PHARMACEUTICALS COM Put 600 49 n/a n/a n/a
2019-05-15 2019-03-31 13F IONIS PHARMACEUTICALS COM Put 600 49 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.